US$ 22.11
biomarkers for glp-1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Impact of GLP- 1 Receptor
Description
Clinical studies have shown that GLP-1 medications are highly effective for weight loss

Ongoing trials are evaluating their potential benefits in populations with type 2 diabetes mellitus and either CKD or MASLD [101,102]

GLP-1 receptor agonists combined with hormone therapy linked to lower endometrial cancer incidence

Preliminary research suggests that allulose may influence the secretion or activity of endogenous GLP-1, potentially offering complementary benefits when used alongside GLP-1-based therapies
